Skip to main content

Asset Dedication, LLC

SEC CIK
0001475896
Latest filing
Jul 30, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Asset Dedication, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
9
Since Q3 2021
Holdings of REGN by Asset Dedication, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−19−100.0%Sold outHolders
Q1 202519$12.1K<0.1%+3+18.8%AddedHolders
Q4 202416$11.4K<0.1%+1+6.7%AddedHolders
Q3 202415$15.8K<0.1%00.0%UnchangedHolders
Q2 202415$15.8K<0.1%00.0%UnchangedHolders
Q1 202415$14.0K<0.1%00.0%UnchangedHolders
Q4 202315$13.0K<0.1%00.0%UnchangedHolders
Q3 202315$12.0K<0.1%+15NewHolders
Q1 20220$00.0%−17−100.0%Sold outHolders
Q4 202117$11.0K<0.1%00.0%UnchangedHolders
Q3 202117$10.0K<0.1%+17NewHolders